(Q33798640)

English

A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

neuropathic pain

0 references

author name string

Ana Navarro

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

María T Saldaña

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Concepción Pérez

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sandra Torrades

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Javier Rejas

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

20 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Neuropathic pain: a practical guide for the clinician

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Economic evaluation of oral treatments for neuropathic pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Algorithm for neuropathic pain treatment: an evidence based proposal.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

What is the most cost-effective treatment for patients with low back pain? A systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Clinical characteristics and economic costs of patients with painful neuropathic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Unmet Needs in the Management of Neuropathic Pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

The clinical picture of neuropathic pain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Neuropathic pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Neurogenic pain syndromes and their management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

4 July 2018

Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

The burden of neuropathic pain: results from a cross-sectional survey.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Work-related disability: results from the American migraine study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Chronic pain and reduced work effectiveness: the hidden cost to Australian employers.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

A cost-utility analysis of pregabalin in the management of peripheral neuropathic pain.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-7

21 January 2018

Consequences of neuropathic pain: quality-of-life issues and associated costs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037328

30 October 2018

Naturalistic study designs in samples with refractory pain: advantages and limitations

1 reference

https://pubmed.ncbi.nlm.nih.gov/21251268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The short-form McGill Pain Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/21251268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A registry of the aetiology and costs of neuropathic pain in pain clinics : results of the registry of aetiologies and costs (REC) in neuropathic pain disorders study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21251268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21251268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2377-11-7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33798640&oldid=2195801609"